🔥 Breakout ↑ Rising Business Why Arrowhead Shot Sky-High, While Ionis Toppled Arrowhead Pharmaceuticals sees a stock surge following positive Phase 3 trial results for its lipid-lowering drug, causing a decline for competitor Ionis. 7 sources 7 articles v 5 just now
◼ Archived Health 🔮 holds ✗ A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses 10 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads. 10 sources 12 articles v 9 4d ago